Eli Lilly, the Indianapolis-based pharmaceutical giant, filed two lawsuits on Sept. 19 in Florida Middle District Court against two pharmacy businesses.

First, the company filed a suit accusing a Florida pharmacy of manufacturing and selling a knock-off version of Lilly’s blockbuster diabetes drug Mounjaro. The suit, backed by King & Spalding, alleges that defendant Archangel Raphael LLC, which operates as Better Life Pharmacy, is selling unapproved drugs purporting to contain tirzepatide, the active pharmaceutical ingredient in Mounjaro. According to the suit, Lilly is the only supplier of FDA-approved tirzepatide drugs in the U.S. Attorneys have not yet appeared for the defendant.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]